DZD8586

· Dizal Pharmaceuticals

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for DZD8586, covering 2025-02-21 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) [Phase 1, Phase 2]